Evidence map›Paper›PMID 34965414›Full record

ArticleCell reports2021

Conserved and divergent features of neuronal CaMKII holoenzyme structure, function, and high-order assembly.

Olivia R Buonarati, Adam P Miller, Steven J Coultrap, K Ulrich Bayer, Steve L Reichow

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Role of CaFrontiers in molecular neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Olivia R BuonaratiDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Adam P MillerDepartment of Chemistry, Portland State University, Portland, OR 97201, USA.
Steven J CoultrapDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
K Ulrich BayerDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: ulli.bayer@cuanschutz.edu.
Steve L ReichowDepartment of Chemistry, Portland State University, Portland, OR 97201, USA. Electronic address: reichow@pdx.edu.
University of Colorado Anschutz Medical Campus · USPortland State University · US

Funding

ZEBRAFISH TRANSGENIC CORE - ROCKY MOUNTAIN NEUROLOGICAL DISORDERS CORE CENTERP30NS048154 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2004 to 2020
$10.1M
CaMKII substrate-selection in opposing forms of synaptic plasticityR01NS081248 · NINDS · UNIVERSITY OF COLORADO DENVER · PI K. Ulrich Bayer · 2013 to 2026
$4.9M
Dynamic Mechanisms of Membrane Channel Gating by CryoEMR35GM124779 · NIGMS · PORTLAND STATE UNIVERSITY · PI Stephen Loen Reichow · 2017 to 2026
$4.2M
CaMKII in global cerebral ischemiaR01NS080851 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BAYER, K. ULRICH, HERSON, PACO S · 2013 to 2017
$2.1M
CaMKII in global cerebral ischemia: mechanisms and therapeutic interventionR01NS118786 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BAYER, K. ULRICH, HERSON, PACO S · 2021 to 2025
$1.9M
Structure, function and aggregation of lens α-crystallins by CryoEMR01EY030987 · NEI · PORTLAND STATE UNIVERSITY · PI REICHOW, STEPHEN LOEN · 2020 to 2024
$1.8M
A-beta/APP signaling impairs CaMKII-dependent synaptic plasticity after ischemic brain injuryF32AG066536 · NIA · UNIVERSITY OF COLORADO DENVER · PI ASFAHA, OLIVIA RUTH · 2020 to 2021
$106k
Suppression of CaMKII synaptic targeting and beta-amyloid pathologyF31AG062160 · NIA · UNIVERSITY OF COLORADO DENVER · PI COOK, SARAH G · 2019 to 2020
$70k
NEI NIH HHS R01 EY030987NIA NIH HHS F31 AG062160NIA NIH HHS F32 AG066536NIGMS NIH HHS R35 GM124779NINDS NIH HHS P30 NS048154NINDS NIH HHS R01 NS080851NINDS NIH HHS R01 NS081248NINDS NIH HHS R01 NS118786
6 · The paper itself

Abstract

Neuronal CaMKII holoenzymes (α and β isoforms) enable molecular signal computation underlying learning and memory but also mediate excitotoxic neuronal death. Here, we provide a comparative analysis of these signaling devices, using single-particle electron microscopy (EM) in combination with biochemical and live-cell imaging studies. In the basal state, both isoforms assemble mainly as 12-mers (but also 14-mers and even 16-mers for the β isoform). CaMKIIα and β isoforms adopt an ensemble of extended activatable states (with average radius of 12.6 versus 16.8 nm, respectively), characterized by multiple transient intra- and inter-holoenzyme interactions associated with distinct functional properties. The extended state of CaMKIIβ allows direct resolution of intra-holoenzyme kinase domain dimers. These dimers could enable cooperative activation by calmodulin, which is observed for both isoforms. High-order CaMKII clustering mediated by inter-holoenzyme kinase domain dimerization is reduced for the β isoform for both basal and excitotoxicity-induced clusters, both in vitro and in neurons.

Indexed as

AnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2FemaleHippocampusHoloenzymesMaleMiceMice, Inbred C57BLNeuronsPhosphorylationProtein ConformationSingle Molecule ImagingCalcium-Calmodulin-Dependent Protein Kinase Type 2HoloenzymesactivationautophosphorylationCaMKIIcell signalingclusteringelectron microscopyholoenzymeintrinsic disorderstructure

Identifiers

PMID34965414
PMCPMC8985225
OpenAlexW4225539576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.